The role of purchasers and payers in the clinical research enterprise workshop summary
Autor Corporativo: | |
---|---|
Otros Autores: | , , |
Formato: | Libro electrónico |
Idioma: | Inglés |
Publicado: |
Washington, D.C. :
National Academy Press
c2002.
|
Edición: | 1st ed |
Materias: | |
Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009621445406719 |
Tabla de Contenidos:
- The Role of Purchasers and Payers in the Clinical Research Enterprise
- Copyright
- REVIEWERS
- Foreword
- Contents
- Workshop Summary
- Introduction to the Workshop
- 1 The Role of Purchasers in the Clinical Research Enterprise
- INTRODUCTION
- WHAT PURCHASERS NEED FROM THE CLINICAL RESEARCH ENTERPRISE
- PHARMACEUTICAL COSTS AND VALUE FOR PURCHASERS
- TRANSLATIONAL BLOCKS
- CHALLENGES FOR PURCHASERS IN THE CLINICAL RESEARCH ENTERPRISE
- PROPOSAL FOR A NATIONAL CLINICAL RESEARCH ENTERPRISE COORDINATING ACTIVITY
- Speaker Response to the Enterprise Coordinating Activity Proposal
- THE IMPORTANCE OF PREVENTION RESEARCH
- CONSUMER INVOLVEMENT
- PUBLICATION OF A RESEARCH PRIORITIES PROPOSAL
- SUMMARY
- 2 The Role of Payers in the Clinical Research Enterprise
- INTRODUCTION
- WHAT PAYERS NEED FROM THE CLINICAL RESEARCH ENTERPRISE
- WHAT PAYERS ARE WILLING TO CONTRIBUTE TO THE CLINICAL RESEARCH ENTERPRISE
- RESEARCH PRIORITIES AND PRIORITY SETTING FOR PAYERS
- TRANSLATIONAL BLOCKS
- CONSUMER DEMAND
- PATIENT PARTICIPATION IN CLINICAL RESEARCH
- SUMMARY
- 3 The Role of Other Stakeholders in the Clinical Research Enterprise
- INTRODUCTION
- THE ROLE OF VOLUNTARY HEALTH ASSOCIATIONS IN THECLINICAL RESEARCH ENTERPRISE
- PRIORITY SETTING IN BASIC AND CLINICAL RESEARCH
- PRIORITY SETTING IN HEALTH SERVICES RESEARCH
- HEALTH SERVICES RESEARCH INVOLUNTARY HEALTH ASSOCIATIONS
- THE ROLE OF THE DEVICE INDUSTRY IN THE CLINICAL RESEARCH ENTERPRISE
- THE ROLE OF THE AGENCY FOR HEALTH CARE RESEARCH AND QUALITY IN THE CLINICAL RESEARCH ENTERPRISE
- TRANSLATIONAL BLOCKS AND PRACTICE GUIDELINES
- SUMMARY
- 4 Opportunities and Challenges in the Clinical Research Enterprise
- INTRODUCTION
- OUTCOMES RESEARCH AND DISEASE MANAGEMENT
- INTEGRATED PATIENT-CENTERED CARE
- RESEARCH PRIORITIES IN PHARMACEUTICAL COMPANIES
- SUMMARY.
- Suggested Readings
- Appendix I Speaker Biographies
- Appendix II Speaker's Company Profiles
- AETNA
- AGENCY FOR HEALTHCARE RESEARCH AND QUALITY
- AMERICAN ASSOCIATION OF HEALTH PLANS
- AMERICAN CANCER SOCIETY
- AMERICAN DIABETES ASSOCIATION
- HEALTHPARTNERS
- MARRIOTT
- MEDICAL TECHNOLOGY LEADERSHIP FORUM
- UNITED HEALTHGROUP
- UNITED PARCEL SERVICE
- VERIZON
- WELLMARK
- Appendix III Purchaser Payer Background Information
- Appendix IV Workshop Agenda
- Appendix V Definitions of Clinical Research and Components of the Enterprise
- DEFINITION OF CLINICAL RESEARCH
- MAJOR COMPONENTS OF THE CLINICAL RESEARCH ENTERPRISE
- Sponsors
- Research Organizations
- Investigators
- Participants
- Oversight Entities
- Stakeholders/Consumers
- Appendix VI Registered Workshop Participants.